Autor: |
Orlando Solis-Coronado, Mónica Patricia Villarreal-Vela, Hazyadee Frecia Rodríguez-Gutiérrez, Juan Francisco González-Guerrero, Ricardo M. Cerda-Flores, Fernando Alcorta-Núñez, Karen Paola Camarillo-Cárdenas, Diana Cristina Pérez-Ibave, Oscar Vidal-Gutiérrez, Genaro A. Ramírez-Correa, María Lourdes Garza-Rodríguez |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Current Oncology; Volume 29; Issue 2; Pages: 1008-1017 |
ISSN: |
1718-7729 |
Popis: |
Breast cancer (BC) has one of the highest incidences and mortality worldwide. Single nucleotide polymorphisms (SNPs) in TOX3 rs3803662 and MMP7 rs1943779 have been associated with susceptibility to BC. In this case-control study, we evaluated the association of rs3803662 (TOX3)/rs1943779 (MMP7) SNPs with clinical features, immunohistochemical reactivity, and risk association with BC in women from northeastern Mexico. We compared 212 BC cases and 212 controls. DNA was isolated from peripheral blood to perform the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. We calculated genotype frequencies, odds ratios, and 95% confidence intervals. We found that CT (Cytocine–Thymine) and TT (Thymine –Thymine) genotypes, and T alleles of TOX3 rs3803662, were associated with BC risk (p = 0.034, p = 0.011, respectively). SNP TOX3 rs3803662 was associated with positive progesterone receptors (PR) and triple-negative BC (TNBC) but not with estrogen receptor (ER) or HER2 reactivity. CT and TT genotypes (p = 0.006) and T alleles (p = 0.002) of SNP MMP7 rs1943779 were associated with risk of BC. We found that T alleles of TOX3 rs3803662 and MMP7 rs1943779 SNPs are associated with BC risk. These findings contribute to personalized medicine in Mexican women. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|